These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 18931525

  • 1. Trial of early neonatal hydrocortisone: two-year follow-up.
    Peltoniemi OM, Lano A, Puosi R, Yliherva A, Bonsante F, Kari MA, Hallman M, Neonatal Hydrocortisone Working Group.
    Neonatology; 2009; 95(3):240-7. PubMed ID: 18931525
    [Abstract] [Full Text] [Related]

  • 2. Pretreatment cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infants.
    Peltoniemi O, Kari MA, Heinonen K, Saarela T, Nikolajev K, Andersson S, Voutilainen R, Hallman M.
    J Pediatr; 2005 May; 146(5):632-7. PubMed ID: 15870666
    [Abstract] [Full Text] [Related]

  • 3. Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone.
    Doyle LW, Davis PG, Morley CJ, McPhee A, Carlin JB, DART Study Investigators.
    Pediatrics; 2007 Apr; 119(4):716-21. PubMed ID: 17403842
    [Abstract] [Full Text] [Related]

  • 4. Early low-dose hydrocortisone in very preterm infants: a randomized, placebo-controlled trial.
    Bonsante F, Latorre G, Iacobelli S, Forziati V, Laforgia N, Esposito L, Mautone A.
    Neonatology; 2007 Apr; 91(4):217-21. PubMed ID: 17568152
    [Abstract] [Full Text] [Related]

  • 5. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease.
    Gross SJ, Anbar RD, Mettelman BB.
    Pediatrics; 2005 Mar; 115(3):681-7. PubMed ID: 15741372
    [Abstract] [Full Text] [Related]

  • 6. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F, Sinha S, Gadzinowski J, D'Agostino R, Segal R, Guardia C, Mazela J, Liu G, SELECT and STAR Study Investigators.
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [Abstract] [Full Text] [Related]

  • 7. Differences in behavioral outcome and motor development at school age after neonatal treatment for chronic lung disease with dexamethasone versus hydrocortisone.
    Karemaker R, Heijnen CJ, Veen S, Baerts W, Samsom J, Visser GH, Kavelaars A, van Doornen LJ, van Bel F.
    Pediatr Res; 2006 Dec; 60(6):745-50. PubMed ID: 17065571
    [Abstract] [Full Text] [Related]

  • 8. Structural and functional brain development after hydrocortisone treatment for neonatal chronic lung disease.
    Lodygensky GA, Rademaker K, Zimine S, Gex-Fabry M, Lieftink AF, Lazeyras F, Groenendaal F, de Vries LS, Huppi PS.
    Pediatrics; 2005 Jul; 116(1):1-7. PubMed ID: 15995023
    [Abstract] [Full Text] [Related]

  • 9. Neonatal hydrocortisone treatment: neurodevelopmental outcome and MRI at school age in preterm-born children.
    Rademaker KJ, Uiterwaal CS, Groenendaal F, Venema MM, van Bel F, Beek FJ, van Haastert IC, Grobbee DE, de Vries LS.
    J Pediatr; 2007 Apr; 150(4):351-7. PubMed ID: 17382109
    [Abstract] [Full Text] [Related]

  • 10. Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants.
    Yoder BA, Harrison M, Clark RH.
    Pediatrics; 2009 Aug; 124(2):673-9. PubMed ID: 19620192
    [Abstract] [Full Text] [Related]

  • 11. Neonatal dexamethasone treatment for chronic lung disease of prematurity alters the hypothalamus-pituitary-adrenal axis and immune system activity at school age.
    Karemaker R, Kavelaars A, ter Wolbeek M, Tersteeg-Kamperman M, Baerts W, Veen S, Samsom JF, Visser GH, van Bel F, Heijnen CJ.
    Pediatrics; 2008 Apr; 121(4):e870-8. PubMed ID: 18381516
    [Abstract] [Full Text] [Related]

  • 12. Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age.
    Baud O, Trousson C, Biran V, Leroy E, Mohamed D, Alberti C, PREMILOC Trial Group.
    JAMA; 2017 Apr 04; 317(13):1329-1337. PubMed ID: 28384828
    [Abstract] [Full Text] [Related]

  • 13. Hydrocortisone vs. dexamethasone treatment for bronchopulmonary dysplasia and their effects on general movements in preterm infants.
    Hitzert MM, Benders MJ, Roescher AM, van Bel F, de Vries LS, Bos AF.
    Pediatr Res; 2012 Jan 04; 71(1):100-6. PubMed ID: 22289857
    [Abstract] [Full Text] [Related]

  • 14. Intrauterine, early neonatal, and postdischarge growth and neurodevelopmental outcome at 5.4 years in extremely preterm infants after intensive neonatal nutritional support.
    Franz AR, Pohlandt F, Bode H, Mihatsch WA, Sander S, Kron M, Steinmacher J.
    Pediatrics; 2009 Jan 04; 123(1):e101-9. PubMed ID: 19117831
    [Abstract] [Full Text] [Related]

  • 15. Hydrocortisone treatment for bronchopulmonary dysplasia and brain volumes in preterm infants.
    Kersbergen KJ, de Vries LS, van Kooij BJ, Išgum I, Rademaker KJ, van Bel F, Hüppi PS, Dubois J, Groenendaal F, Benders MJ.
    J Pediatr; 2013 Sep 04; 163(3):666-71.e1. PubMed ID: 23706359
    [Abstract] [Full Text] [Related]

  • 16. Hydrocortisone administration for the treatment of refractory hypotension in critically ill newborns.
    Baker CF, Barks JD, Engmann C, Vazquez DM, Neal CR, Schumacher RE, Bhatt-Mehta V.
    J Perinatol; 2008 Jun 04; 28(6):412-9. PubMed ID: 18337742
    [Abstract] [Full Text] [Related]

  • 17. Controlled trial of dexamethasone in neonatal chronic lung disease: an 8-year follow-up of cardiopulmonary function and growth.
    Mieskonen S, Eronen M, Malmberg LP, Turpeinen M, Kari MA, Hallman M.
    Acta Paediatr; 2003 Aug 04; 92(8):896-904. PubMed ID: 12948063
    [Abstract] [Full Text] [Related]

  • 18. Follow-up of a randomized, placebo-controlled trial of dexamethasone to decrease the duration of ventilator dependency in very low birth weight infants: neurodevelopmental outcomes at 4 to 11 years of age.
    O'Shea TM, Washburn LK, Nixon PA, Goldstein DJ.
    Pediatrics; 2007 Sep 04; 120(3):594-602. PubMed ID: 17766533
    [Abstract] [Full Text] [Related]

  • 19. A randomized-controlled trial of prophylactic hydrocortisone supplementation for the prevention of hypotension in extremely low birth weight infants.
    Efird MM, Heerens AT, Gordon PV, Bose CL, Young DA.
    J Perinatol; 2005 Feb 04; 25(2):119-24. PubMed ID: 15329742
    [Abstract] [Full Text] [Related]

  • 20. Two-year follow-up of a randomised trial with repeated antenatal betamethasone.
    Peltoniemi OM, Kari MA, Lano A, Yliherva A, Puosi R, Lehtonen L, Tammela O, Hallman M, Repeat Antenatal Betamethasone (RepeatBM) Follow-Up Study Group.
    Arch Dis Child Fetal Neonatal Ed; 2009 Nov 04; 94(6):F402-6. PubMed ID: 19531521
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.